logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Aref Al-Kali

Mayo Clinic
H指数:42
被引数:7,063

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic impact of need for re-induction based on day-14 residual disease and age-adapted consolidation strategy in acute myeloid leukemia

基于第14天残留病灶和年龄适应巩固策略的再诱导需求对急性髓系白血病预后的影响

Blood Cancer Journal
IF11.6
2026-09-300
OAAI
Abiola Bolarinwa; Muhammad Yousuf; Aref Al-Kali; Hassan B. Alkhateeb; Abhishek A. Mangaonkar; Antoine N. Saliba; Mehrdad Hefazi Torghabeh; Aasiya Matin; Michelle A. Elliott; Mark R. Litzow; William J. Hogan; Mithun V. Shah; Mrinal M. Patnaik; Animesh Pardanani; Dong Chen; Kaaren K. Reichard; Rong He; Naseema Gangat; Ayalew Tefferi; Kebede H. Begna
Venetoclax Plus Hypomethylating Agent for 7- Versus 14- Versus 21- Versus 28-Day Cycles in Newly-Diagnosed Acute Myeloid Leukemia: ELN and Mayo Genetic Risk–Stratified Analysis in 540 Patients

维奈克拉联合去甲基化药物用于新诊断急性髓系白血病7天、14天、21天及28天疗程：基于ELN和Mayo遗传风险分层的540例患者分析

American Journal of Hematology
IF9.9
2026-09-180
PRE
Sudhesh Kumar; Momna Warraich; Mahnoor Fatima; Kristen McCullough; Aref Al-Kali; Hassan B. Alkhateeb; Kebede H. Begna; Abhishek A. Mangaonkar; Antoine N. Saliba; Mark R. Litzow; William Hogan; Mithun Shah; Mrinal M. Patnaik; Animesh Pardanani; Talha Badar; James Foran; Jeanne Palmer; Cecilia Arana Yi; Ayalew Tefferi; Naseema Gangat
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)

基于低甲基化制剂治疗的反应对高风险骨髓增生异常综合征/肿瘤患者生存结局的影响：考虑基线临床-分子风险和移植状态的国际骨髓增生异常综合征联盟(icMDS)分析

American Journal of Hematology
IF9.9
2026-08-280
PRE
Benjamin Rolles; Jan Philipp Bewersdorf; Tariq Kewan; Ondrej Blaha; Jessica M. Stempel; Luca Lanino; Najla H. Al Ali; Amy E. DeZern; Mikkael A. Sekeres; Geoffrey L. Uy; Samuel Urrutia; Hetty E. Carraway; Pinkal Desai; Elizabeth A. Griffiths; Eytan M. Stein; Andrew M. Brunner; Christine McMahon; Rory M. Shallis; Joshua F. Zeidner; Michael R. Savona; Shougat Barua; Namrata Sonia Chandhok; Constantine Logothetis; Aram Bidikian; Ted M. Getz; Gail J. Roboz; Eunice S. Wang; Amyah C. Harris; Maria L. Amaya; Hayley Hawkins; Somedeb Ball; Justin Grenet; Parisa Abedi; Shai Shimony; R. Coleman Lindsley; Zhuoer Xie; Yazan F. Madanat; Yasmin Abaza; Talha Badar; Torsten Haferlach; Jaroslaw P. Maciejewski; David Sallman; Anoop Enjeti; Kamal Al-Rabi; Khalid Halahleh; Devendra Hiwase; Maria Diez-Campelo; David Valcarcel; Claudia Haferlach; Lisa Pleyer; Ioannis Kotsianidis; Vasiliki Pappa; Valeria Santini; Angela Consagra; Aref Al-Kali; Seishi Ogawa; Yasuhito Nannya; Matteo Giovanni Della Porta; Rami S. Komrokji; Amer M. Zeidan; Maximilian Stahl
Determinants of survival after failure of frontline venetoclax plus hypomethylating agent therapy in 356 patients with newly diagnosed acute myeloid leukemia

356例新诊断急性髓系白血病患者一线维奈克拉联合去甲基化药物治疗失败后的生存影响因素

Blood Cancer Journal
IF11.6
2026-08-170
OAAI
Mahnoor Fatima; Sudhesh Kumar; Momna Warraich; Kristen McCullough; Aref Al-Kali; Hassan B. Alkhateeb; Kebede H. Begna; Abhishek Mangaonkar; Antoine N. Saliba; Mark R. Litzow; William Hogan; Mithun V. Shah; Mrinal M. Patnaik; Animesh Pardanani; Talha Badar; James Foran; Jeanne Palmer; Cecilia Arana Yi; Ayalew Tefferi; Naseema Gangat
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients

CPX-351（脂质体阿糖胞苷和柔红霉素）与维奈克拉联合表观遗传药物疗法在初诊急性髓系白血病中的比较：一项涉及600例梅奥诊所患者的回顾性比较研究

Blood Cancer Journal
IF11.6
2026-04-060
OAAI
Saubia Fathima; Lior Rokach; Nour Ghosoun; Mahsa Rezasoltani; Rimal Ilyas; Ali Alsugair; Kristen McCullough; Maymona Abdelmagid; Aref Al-Kali; Hassan B. Alkhateeb; Kebede H. Begna; Abhishek A. Mangaonkar; Aasiya Matin; Antoine N. Saliba; Mehrdad Hefazi Torghabeh; Mark R. Litzow; William Hogan; Mithun Shah; Mrinal M. Patnaik; Animesh Pardanani; Talha Badar; Hemant Murthy; James Foran; Jeanne Palmer; Nathan Punwani; Lisa Sproat; Nandita Khera; Cecilia Arana Yi; Ayalew Tefferi; Naseema Gangat
Distinct advantages for risk scoring models in patients with clonal cytopenia of undetermined significance

克隆性细胞减少症未定意义患者风险评分模型的独特优势

British Journal of Haematology
IF3.8
2026-02-250
PRE
Yazan Jabban; Rong He; Kurt Bessonen; Patricia Greipp; Dragan Jevremovic; David S. Viswanatha; James M. Foran; Talha Badar; Cecilia Arana Yi; Yael N. Kusne; Antoine N. Saliba; Mehrdad Hefazi; Aasiya Matin; William J. Hogan; Abhishek A. Mangaonkar; Mithun Vinod Shah; Hassan B. Alkhateeb; Mrinal M. Patnaik; Aref Al-Kali
Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatment

新诊断急性髓系白血病未接受治疗患者的特征

Haematologica
IF7.9
2026-01-010
OA
Alkabbani, Oudai; Jabban, Yazan; He, Rong; Viswanatha, David; Bessonen, Kurt; Greipp, Patricia; Jevremovic, Dragan; Foran, James M.; Badar, Talha; Yi, Cecilia Arana; Kusne, Yael; Saliba, Antoine N.; Torghabeh, Mehrdad Hefazi; Matin, Aasiya; Hogan, William J.; Mangaonkar, Abhishek; Alkhateeb, Hassan; Patnaik, Mrinal; Shah, Mithun; Begna, Kebede; Litzow, Mark R.; Al-Kali, Aref
The RNA N6-methyladenosine methylome coordinates long non-coding RNAs to mediate cancer drug resistance by activating PI3K signaling

RNA N6-甲基腺苷甲基化组通过激活PI3K信号通路，协调长链非编码RNA以介导癌症耐药性。

Cell Death & Disease
IF9.6
2025-11-070
OAAI
Yanhong Tan; Changli Zhou; Sicheng Bian; Huiqin Bian; Yanan Ren; Wencke Walter; Jiuxia Pang; Tao Cheng; Hongwei Wang; Yuchao Yang; Wenzheng Guo; Lingli Zhang; Aref Al-Kali; Mark R. Litzow; Xiaonan Han; Jianhua Yu; Rendong Yang; Gang Huang; Gregor Hoermann; William Tse; Shujun Liu
Clinical and Prognostic Impact of Allelic Status in EZH2-Mutated Myeloid Neoplasms

EZH2突变髓系肿瘤中等位基因状态的临床及预后影响

Hematological Oncology
IF3.9
2025-10-230
PRE
Muhamad Oum; Ahmad Nanaa; Yazan Jabban; David Viswanatha; Rong He; Dragan Jevremovic; James M. Foran; Talha Badar; Cecilia Arana Yi; Patricia T. Greipp; Aasiya Matin; Mehrdad Hefazi; William J. Hogan; Antoine N. Saliba; Mrinal Patnaik; Abhishek A. Mangaonkar; Mithun Shah; Hassan B. Alkhateeb; Aref Al-Kali
Applicability of current prognostication models for MDS patients with DDX41 mutation

DDX41突变伴发MDS患者现有预后模型的适用性

LEUKEMIA RESEARCH
IF2.2
2025-10-010
PRE
Toumeh, Nadia; Jabban, Yazan; He, Rong; Viswanatha, David; Jevremovic, Dragan; Greipp, Patricia T.; Foran, James M.; Badar, Talha; Yi, Cecilia Y. Arana; Kusne, Yael; Saliba, Antoine N.; Thorghabeh, Mehrdad Hefazi; Matin, Aasiya; Hogan, William J.; Shah, Mithun, V; Mangaonkar, Abhishek A.; Patnaik, Mrinal M.; Alkhateeb, Hassan B.; Al-Kali, Aref
Landscape and clinicopathologic features of RAS pathway mutations in chronic myelomonocytic leukemia

RAS通路突变在慢性髓单核细胞白血病中的景观及临床病理特征

Blood Advances
IF7.1
2025-07-150
OAAI
Guillermo Montalban-Bravo; Sanam Loghavi; Ziyi Li; Kelly Chien; Rashmi Kanagal-Shamanna; Alex Bataller; Anuya Natu; Mark Gurney; Alexandre Bazinet; Danielle Hammond; Koji Sasaki; Gautam Borthakur; Mahesh Swaminathan; Courtney DiNardo; Tapan Kadia; Farhad Ravandi; Naval Daver; Nicholas Short; Naveen Pemmaraju; Ghayas Issa; Terra L. Lasho; Christy M. Finke; Aref Al-Kali; Clifford Csizmar; Hassan Alkhateeb; Naseema Gangat; Abhishek A. Mangaonkar; Carlos Bueso-Ramos; Ayalew Tefferi; Hagop Kantarjian; Guillermo Garcia-Manero; Mrinal M. Patnaik
Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes

多个TET2突变在骨髓增生异常和骨髓增生性慢性粒单核细胞白血病亚型中均带来额外的生存益处

Leukemia
IF13.4
2025-06-240
PRE
Clifford M. Csizmar; Anuya Natu; Mark Gurney; Saubia Fathima; Ali Khalid A. Alsugair; Rashmi Kanagal-Shamanna; Sanam Loghavi; Alexandre Bazinet; Kelly Chien; Danielle Hammond; Courtney DiNardo; Tapan Kadia; Farhad Ravandi-Kashani; Naveen Pemmaraju; Koji Sasaki; Terra L. Lasho; Christy M. Finke; Aref Al-Kali; Hassan Alkhateeb; Kebede Begna; Naseema Gangat; Mehrdad Hefazi Torghabeh; Aasiya Matin; Abhishek A. Mangaonkar; Antoine N. Saliba; Ayalew Tefferi; Guillermo Garcia-Manero; Hagop M. Kantarjian; Rami S. Komrokji; Zhuoer Xie; Najla A. Ali; David Sallman; Eric Padron; Guillermo Montalban-Bravo; Mrinal M. Patnaik
RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm

RAS突变识别出治疗相关性髓系肿瘤的不良预后分子亚型

Blood Advances
IF7.1
2025-05-260
OA
Chung Hoow Kok; Aref Al-Kali; Daniel Thomas; Rong He; Monika M. Kutyna; Hassan Alkhateeb; Kelly Lim; Antoine N. Saliba; Carla Toop; Aasiya Matin; Hamish Scott; Naseema Gangat; Anna Brown; Abhishek Mangaonkar; Christopher N. Hahn; Kebede Begna; Kevin Hung; Patricia Greipp; William J. Hogan; Mrinal Patnaik; Mithun Shah; Devendra K. Hiwase
Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases

骨髓增殖性肿瘤和急性髓系白血病中的多突变TP53基因突变：142例有信息价值病例的生存和风险因素比较分析

AMERICAN JOURNAL OF HEMATOLOGY
IF0
2025-03-131
PRE
Fathima, S; Abdelmagid, M; Alsugair, A; Begna, KH; Al-Kali, A; Mangaonkar, AA; Pardanani, AD; Patnaik, MM; Mendoza, CJZ; He, R; Reichard, KK; Badar, T; Foran, JM; Palmer, J; Loscocco, GG; Guglielmelli, P; Vannucchi, AM; Orazi, A; Arber, DA; Hiwase, D; Shah, MV; Gangat, N; Tefferi, A
A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndrome

durvalumab单药治疗或联合tremelimumab加或不加阿扎胞苷治疗骨髓增生异常综合征患者的1期研究

ANNALS OF HEMATOLOGY
IF2.4
2025-03-010
OAAI
Garcia-Manero, Guillermo; Gaddh, Manila; Platzbecker, Uwe; Lindsley, R. Coleman; Larson, Sarah M.; Chevassut, Timothy; Fenaux, Pierre; Komrokji, Rami; Lyons, Roger; Al-Kali, Aref; Jiang, Yu; Bothos, John; Townsley, Danielle M.; Zeidan, Amer M.
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax plus Hypomethylating Agent
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-12-131
OAAI
Gangat, Naseema; Elbeih, Azeem; Ghosoun, Nour; Mccullough, Kristen; Aperna, Fnu; Johnson, Isla M.; Abdelmagid, Maymona; Al-Kali, Aref; Alkhateeb, Hassan B.; Begna, Kebede H.; Elliott, Michelle; Mangaonkar, Abhishek; Matin, Aasiya; Saliba, Antoine N.; Torghabeh, Mehrdad Hefazi; Litzow, Mark R.; Hogan, William; Shah, Mithun; Patnaik, Mrinal M.; Pardanani, Animesh; Badar, Talha; Murthy, Hemant; Foran, James; Palmer, Jeanne; Sproat, Lisa; Khera, Nandita; Yi, Cecilia Arana; Yates, Samuel; Sneider, Abigail; Dworkin, Emily; Patel, Anand A.; Bazinet, Alexandre; Senapati, Jayastu; Bataller, Alex; Dinardo, Courtney; Kadia, Tapan; Tefferi, Ayalew

研究方向

暂未获取到该数据
N
Naseema Gangat
H 指数:64论文数:779被引数:2.0万
A
Ayalew Tefferi
H 指数:152论文数:2,062被引数:10.2万
M
Mrinal M. Patnaik
H 指数:72论文数:1,243被引数:1.9万
M
Mark R. Litzow
H 指数:106论文数:1,324被引数:4.7万
K
Kebede H. Begna
H 指数:37论文数:323被引数:6,741
W
William J. Hogan
H 指数:62论文数:962被引数:1.5万
H
Hassan B. Alkhateeb
H 指数:26论文数:426被引数:2,558
A
Animesh Pardanani
H 指数:102论文数:807被引数:4.0万
A
Abhishek A. Mangaonkar
H 指数:30论文数:394被引数:3,366
M
Mithun Vinod Shah
H 指数:35论文数:450被引数:4,556